Genetics of Moyamoya disease

Journal of Human Genetics

Volumn 55, Issue 11, 2010, Pages 711-716

  Roder, Constantin ^a   Nayak, Nikhil R ^b   Khan, Nadia ^c   Tatagiba, Marcos ^a   Inoue, Ituro ^d   Krischek, Boris ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

genetics; Moyamoya disease; stroke

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; LEUKOCYTE ANTIGEN;

BINDING SITE; BRAIN PERFUSION; CASE CONTROL STUDY; CHROMOSOME 17Q; CHROMOSOME 8Q; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; LINKAGE ANALYSIS; MARFAN SYNDROME; MOYAMOYA DISEASE; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PSYCHOMOTOR DEVELOPMENT; REVASCULARIZATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CAROTID ARTERY, INTERNAL; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MOYAMOYA DISEASE;

EID: 78649521954     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.103     Document Type: Review

References (52)

1. Takeuchi, K. & Shimizu, K. Hypoplasia of the bilateral internal carotid arteries. Brain Nerve. 9, 37-43 (1957).
2. Suzuki, J. & Takaku, A. Cerebrovascular 'moyamoya' disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 20, 288-299 (1969).
3. Fukui, M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya'disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin. Neurol. Neurosurg. 99, S238 (1997).
4. Yonekawa, Y. & Taub, E. Moyamoya disease: status 1998. Neurologist. 5, 13-23 (1999).
5. Khan, N. & Yonekawa, Y. Moyamoya angiopathy in Europe: 'The Zürich experience'. Stroke Rev. 9, 181-188 (2005).
6. Uchino, K., Johnston, S. C., Becker, K. J. & Tirschwell, D. L. Moyamoya disease in Washington state and California. Neurology. 65, 956-958 (2005).
7. Baba, T., Houkin, K. & Kuroda, S. Novel epidemiological features of moyamoya disease. Br. Med. J. 79, 900-904 (2008).
8. Wakai, K., Tamakoshi, A., Ohno, Y., Kawamura, T., Ikezaki, K. & Fukui, M. Epidemiology of spontaneous occlusion of the circle of Willis: results of national epidemiologic survey. The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan: Annual Report 1995 33-37 (1995).
9. Fukui, M. Current state of study on moyamoya disease in Japan. Surg. Neurol. 47, 138-143 (1997). (Pubitemid 27074166)
10. Ikezaki, K., Han, D. H., Kawano, T., Kinukawa, N. & Fukui, M. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 28, 2513-2517 (1997).
11. Iwama, T. & Yoshimura, S. Present status of Moyamoya disease in Japan. Acta. Neurochir. (Wien). 103, 115-118 (2008).
12. Scott, R. M. & Smith, E. R. Moyamoya disease and Moyamoya syndrome. N. Engl. J. Med. 360, 1226-1237 (2009).
13. Ikezaki, K. Rational approach to treatment of Moyamoya disease in childhood. J. Child Neurol. 15, 350-356 (2000).
14. Khan, N., Schuknecht, B., Boltshauser, E., Capone, A., Buck, A., Imhof, H. et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascu-larisation procedures. Acta. Neurochir. (Wien). 145, 1061-1071 (2003).
15. Matsushima, Y., Aoyagi, M., Suzuki, R., Nariai, T., Shishido, T. & Hirakawa, K. Dual anastomosis for pediatric moyamoya patients using the anterior and the posterior branches of the superficial temporal artery. Nerv. Syst. Child. 18, 27-32 (1993).
16. Takagi, Y., Kikuta, K., Nozaki, K. & Hashimoto, N. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol. Med. Chir. (Tokyo). 47, 1-4 (2007).
17. Ullrich, N. J., Robertson, R., Kinnamon, D. D., Scott, R. M., Kieran, M. W., Turner, C. D. et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 68, 932-938 (2007).
18. Yamada, H., Deguchi, K., Tanigawara, T., Takenaka, K., Nishimura, Y., Shinoda, J. et al. The relationship between Moyamoya disease and bacterial infection. Clin. Neurol. Neurosurg. 99, S221 (1997).
19. Fukuyama, S., Kanai, M. & Osawa, M. Clinical genetic analysis on the Moyamoya disease. The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan: Annual report 1990 53-59 (1990).
20. Osawa, M., Kanai, N., Kawai, M. & Fukuyama, Y. Clinical genetic study on the idiopathic occlusion of the circle of Willis. The research committee on spontaneous occlusion of the circle of Willis (Moyamoya disease) of the Ministry of Health and Welfare in Japan. Annual Report Tokyo, Japan: Ministry of Health and Welfare, Japan 147-152 (1992).
21. Yamauchi, T., Houkin, K., Tada, M. & Abe, H. Familial occurrence of moyamoya disease. Clin. Neurol. Neurosurg. 99, 159-164 (1997).
22. Nanba, R., Kuroda, S., Tada, M., Ishikawa, T., Houkin, K. & Iwasaki, Y. Clinical features of familial moyamoya disease. Childs Nerv. Syst. 22, 258-262 (2006).
23. Kuroda, S. & Houkin, K. Moyamoya disease: current concepts and future perspectives. Lancet. Neurol. 7, 1056-1066 (2008).
24. Smith, E. R. & Scott, R. M. Surgical management of moyamoya syndrome. Skull Base. 15, 15 (2005).
25. Inoue, T. K., Ikezaki, K., Sasazuki, T., Matsushima, T. & Fukui, M. Analysis of class II genes of human leukocyte antigen in patients with Moyamoya disease. Clin. Neurol. Neurosurg. 99, S229-S232 (1997).
26. Ikeda, H., Sasaki, T., Yoshimoto, T., Fukui, M. & Arinami, T. Mapping of a familial moyamoya disease gene to chromosome 3p24. 2-p26. Am. J. Hum. Genet. 64, 533-537 (1999).
27. Collod, G., Babron, M. C., Jondeau, G., Coulon, M., Weissenbach, J., Dubourg, O. et al. A second locus for Marfan syndrome maps to chromosome 3p24. 2-p25. Nat. Genet. 8, 264 (1994).
28. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260, 1317-1320 (1993). (Pubitemid 23231974)
29. Inoue, T. K., Ikezaki, K., Sasazuki, T., Ono, T., Kamikawaji, N., Matsushima, T. et al. DNA typing of HLA in the patients with moyamoya disease. J. Hum. Genet. 42, 507-515 (1997). (Pubitemid 28104146)
30. Inoue, T. K., Ikezaki, K., Sasazuki, T., Matsushima, T. & Fukui, M. Linkage analysis of moyamoya disease on chromosome 6. J. Child Neurol. 15, 179-182 (2000).
31. Yamauchi, T., Tada, M., Houkin, K., Tanaka, T., Nakamura, Y., Kuroda, S. et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of willis) to chromosome 17q25. Stroke. 31, 930-935 (2000).
32. Xu, G. F., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M. et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608 (1990).
33. Barrall, J. L. & Summers, C. G. Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis. Surv. Ophthalmol. 40, 500-504 (1996).
34. Edwards Brown, M. K. & Quets, J. P. Midwest experience with moyamoya disease. Clin. Neurol. Neurosurg. 99, 36-38 (1997).
35. Woody, R. C., Perrot, L. J. & Beck, S. A. Neurofibromatosis cerebral vasculopathy in an infant: clinical, neuroradiographic, and neuropathologic studies. Fetal. Pediatr. Pathol. 12, 613-619 (1992).
36. Kwong, K. L. & Wong, Y. C. Moyamoya disease in a child with neurofibromatosis type-1. J. Paediatr. Child Health. 35, 108-109 (1999).
37. Aoyagi, M., Ogami, K., Matsushima, Y., Shikata, M., Yamamoto, M. & Yamamoto, K. Human leukocyte antigen in patients with Moyamoya disease. Stroke. 26, 415-417 (1995).
38. Han, H., Pyo, C., Yoo, D., Huh, P., Cho, K. & Kim, D. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J. Korean Med. Sci. 18, 876-880 (2003). (Pubitemid 38072941)
39. Sakurai, K., Horiuchi, Y., Ikeda, H., Ikezaki, K., Yoshimoto, T., Fukui, M. et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J. Hum. Genet. 49, 278-281 (2004).
40. Nanba, R., Tada, M., Kuroda, S., Houkin, K. & Iwasaki, Y. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv. Syst. 21, 62-68 (2005).
41. Kang, H. S., Kim, S. K., Cho, B. K., Kim, Y. Y., Hwang, Y. S. & Wang, K. C. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 58, 1074-1080 (2006).
42. Johnson, C. & Galis, Z. S. Matrix metalloproteinase-2 and-9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler. Thromb. Vasc. Biol. 24, 54 (2004).
43. Dollery, C. M., McEwan, J. R., Wang, M., Sang, Q. A., Liu, Y. E. & Shi, Y. E. TIMP-4 is regulated by vascular injury in rats. Ann. N. Y. Acad. Sci. 84, 498-504 (1999). (Pubitemid 29138586)
44. Hasenstab, D., Forough, R. & Clowes, A. W. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. Circ. Res. 80, 490-496 (1997).
45. Shi, Y., Patel, S., Niculescu, R., Chung, W., Desrochers, P. & Zalewski, A. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler. Thromb. Vasc. Biol. 19, 1150-1155 (1999).
46. Paszkowiak, J. J. & Dardik, A. Arterial wall shear stress: observations from the bench to the bedside. Vasc. Endovascular Surg. 37, 47 (2003).
47. Mineharu, Y., Takenaka, K., Yamakawa, H., Inoue, K., Ikeda, H., Kikuta, K. I. et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J. Neurol. Neurosurg. Psychiatry. 77, 1025-1029 (2006).
48. Mineharu, Y., Liu, W., Inoue, K., Matsuura, N., Inoue, S., Takenaka, K. et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 70, 2357-2363 (2008
49. Guo, D.-C., Papke, C. L., Tran-Fadulu, V., Regalado, E. S., Avidan, N., Johnson, R. J. et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am. J. Hum. Genet. 84, 617-627 (2009).
50. Hong, S., Wang, K., Kim, S., Cho, B. & Park, M. Association of HLA-DR and-DQ genes with familial moyamoya disease in Koreans. J. Korean Neurosurg. Soc. 46, 558-563 (2009).
51. Liu, W., Hashikata, H., Inoue, K., Matsuura, N., Mineharu, Y., Kobayashi, H. et al. A rare Asian founder polymorphism of RAPTOR may explain the high prevalence of moyamoya disease among East Asians and its low prevalence among Caucasians. Env. Health Prev. Med. 1-11 (2009).
52. Roder, C., Peters, V., Kasuya, H., Nishizawa, T., Takehara, Y., Berg, D. et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta. Neurochir. (Wien). (2010). (e-pub ahead of print 23 June 2010; DOI 10.1007/s00701-00010-00711-00709).